Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more
Haemonetics Corporation (HAE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.103x
Based on the latest financial reports, Haemonetics Corporation (HAE) has a cash flow conversion efficiency ratio of 0.103x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($93.56 Million) by net assets ($911.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Haemonetics Corporation - Cash Flow Conversion Efficiency Trend (1992–2025)
This chart illustrates how Haemonetics Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Haemonetics Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haemonetics Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Graham Holdings Co
NYSE:GHC
|
0.039x |
|
YUNDA Holding Co Ltd
SHE:002120
|
0.036x |
|
Hainan Mining Co Ltd
SHG:601969
|
0.076x |
|
ASR Microelectronics Co. Ltd. A
SHG:688220
|
N/A |
|
Penske Automotive Group Inc
NYSE:PAG
|
0.055x |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
0.040x |
|
McGrath RentCorp
NASDAQ:MGRC
|
0.065x |
|
Waaree Energies Limited
NSE:WAAREEENER
|
0.088x |
Annual Cash Flow Conversion Efficiency for Haemonetics Corporation (1992–2025)
The table below shows the annual cash flow conversion efficiency of Haemonetics Corporation from 1992 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $820.84 Million | $181.72 Million | 0.221x | +16.93% |
| 2024-03-31 | $959.96 Million | $181.75 Million | 0.189x | -43.28% |
| 2023-03-31 | $818.00 Million | $273.06 Million | 0.334x | +45.22% |
| 2022-03-31 | $749.42 Million | $172.26 Million | 0.230x | +54.57% |
| 2021-03-31 | $731.67 Million | $108.81 Million | 0.149x | -44.82% |
| 2020-03-31 | $587.11 Million | $158.22 Million | 0.269x | +13.00% |
| 2019-03-31 | $667.87 Million | $159.28 Million | 0.238x | -18.56% |
| 2018-03-31 | $752.43 Million | $220.35 Million | 0.293x | +35.59% |
| 2017-03-31 | $739.61 Million | $159.74 Million | 0.216x | +27.60% |
| 2016-03-31 | $719.98 Million | $121.86 Million | 0.169x | +9.95% |
| 2015-03-31 | $826.12 Million | $127.18 Million | 0.154x | -7.36% |
| 2014-03-31 | $839.61 Million | $139.52 Million | 0.166x | +50.25% |
| 2013-03-31 | $769.18 Million | $85.07 Million | 0.111x | -29.50% |
| 2012-03-31 | $735.08 Million | $115.32 Million | 0.157x | -12.81% |
| 2011-03-31 | $686.14 Million | $123.45 Million | 0.180x | -18.33% |
| 2010-03-31 | $593.12 Million | $130.67 Million | 0.220x | +2.21% |
| 2009-03-31 | $539.88 Million | $116.36 Million | 0.216x | +37.14% |
| 2008-03-31 | $494.19 Million | $77.67 Million | 0.157x | -9.79% |
| 2007-03-31 | $479.65 Million | $83.56 Million | 0.174x | -10.13% |
| 2006-03-31 | $441.65 Million | $85.62 Million | 0.194x | -3.32% |
| 2005-03-31 | $355.13 Million | $71.21 Million | 0.201x | -24.82% |
| 2004-03-31 | $279.75 Million | $74.61 Million | 0.267x | +36.35% |
| 2003-03-31 | $223.24 Million | $43.67 Million | 0.196x | +43.70% |
| 2002-03-31 | $236.82 Million | $32.24 Million | 0.136x | -51.91% |
| 2001-03-31 | $215.52 Million | $61.01 Million | 0.283x | +9.31% |
| 2000-03-31 | $206.44 Million | $53.47 Million | 0.259x | +70.53% |
| 1999-03-31 | $221.90 Million | $33.70 Million | 0.152x | +44.95% |
| 1998-03-31 | $194.70 Million | $20.40 Million | 0.105x | -11.59% |
| 1997-03-31 | $225.30 Million | $26.70 Million | 0.119x | -53.07% |
| 1996-03-31 | $217.00 Million | $54.80 Million | 0.253x | +212.75% |
| 1995-03-31 | $193.20 Million | $15.60 Million | 0.081x | -51.91% |
| 1994-03-31 | $160.80 Million | $27.00 Million | 0.168x | -40.74% |
| 1993-03-31 | $126.70 Million | $35.90 Million | 0.283x | +36.55% |
| 1992-03-31 | $90.60 Million | $18.80 Million | 0.208x | -- |